Swedbank
EW icon

Swedbank’s Edwards Lifesciences EW Stock Holding History

Swedbank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1M Buy
321,356
+11,640
+4% +$975K 0.03% 323
2026
Q1 		$24.8M Buy
309,716
+2,153
+0.7% +$178K 0.03% 341
2025
Q4 		$26.2M Sell
307,563
-192,442
-38% -$15.8M 0.03% 334
2025
Q3 		$38.9M Buy
500,005
+29,752
+6% +$2.32M 0.04% 260
2025
Q2 		$36.8M Sell
470,253
-95,157
-17% -$7.1M 0.04% 260
2025
Q1 		$41M Sell
565,410
-215,076
-28% -$15.4M 0.05% 225
2024
Q4 		$57.8M Sell
780,486
-189,026
-19% -$13.2M 0.07% 189
2024
Q3 		$64M Sell
969,512
-259,245
-21% -$18.8M 0.08% 181
2024
Q2 		$114M Buy
+1,228,757
New +$109M 0.15% 115
2024
Q1 		– Sell
-1,493,978
Closed -$114M – 626
2023
Q4 		$114M Sell
1,493,978
-25,246
-2% -$1.76M 0.18% 101
2023
Q3 		$105M Sell
1,519,224
-157,467
-9% -$12.7M 0.18% 105
2023
Q2 		$158M Buy
1,676,691
+136,714
+9% +$11.9M 0.27% 74
2023
Q1 		$127M Sell
1,539,977
-71,397
-4% -$5.61M 0.25% 86
2022
Q4 		$120M Sell
1,611,374
-2,232
-0.1% -$172K 0.26% 85
2022
Q3 		$133M Buy
1,613,606
+101,340
+7% +$9.75M 0.32% 65
2022
Q2 		$144M Sell
1,512,266
-44,126
-3% -$4.57M 0.32% 65
2022
Q1 		$183M Sell
1,556,392
-14,199
-0.9% -$1.59M 0.34% 64
2021
Q4 		$205M Buy
1,570,591
+3,819
+0.2% +$445K 0.34% 55
2021
Q3 		$177M Sell
1,566,772
-1,015
-0.1% -$116K 0.33% 56
2021
Q2 		$162M Buy
1,567,787
+14,944
+1% +$1.41M 0.3% 65
2021
Q1 		$130M Buy
1,552,843
+37,761
+2% +$3.19M 0.27% 80
2020
Q4 		$136M Buy
1,515,082
+163,441
+12% +$13.6M 0.4% 74
2020
Q3 		$108M Sell
1,351,641
-212,957
-14% -$16.6M 0.37% 79
2020
Q2 		$108M Buy
+1,564,598
New +$111M 0.39% 78

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank's EW Position: Q2 2026 in Review

Swedbank increased its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, buying an estimated $975K and bringing the position to 321,356 shares worth $29.1M. The position accounts for 0.03% of the portfolio, ranked #323.

Swedbank first reported a position in EW in Q2 2020 and has held it in 24 quarters since. The position peaked at $205M in Q4 2021. 265 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Swedbank held 321,356 shares of Edwards Lifesciences worth $29.1M as of Q2 2026.
  • Swedbank bought 11,640 Edwards Lifesciences shares in Q2 2026, an estimated $975K.
  • Edwards Lifesciences made up 0.03% of Swedbank's portfolio in Q2 2026, its #323 holding.
  • Swedbank first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 24 quarters since.
  • Swedbank's Edwards Lifesciences position peaked at $205M in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.